Project Details
Description
ABSTRACT
IL-33 is a recently discovered member of the IL-1 family of cytokines. Administration of
recombinant IL-33 has been shown to have profound effects on a diverse range of diseases, including
arthritis, infection and allergy that are mediated though its receptor ST2. Several different cell
types have been shown to express IL-33 and we, and others, have shown that epithelial cells have a
high constitutive expression and release it during damage. Consequently, IL-33 has been coined an
“alarmin”, important for the communication between tissue cells and the immune response. However,
we have demonstrated that inflammatory cells, such as mast cells [and dendritic cells], have low
levels at rest but are induced to express IL-33 upon their activation. The functional consequences
of these different sources of IL-33 have not been studied and determining these is the basis for
our study.
Our preliminary data establishes that ST2 is necessary for both the sensitization to allergens, as
well as efficiently mounting an inflammatory response when sensitization in bypassed.
Interestingly, our findings show that ST2 is only required for sensitization through the intestine
and that, by injecting the same antigen, ST2 KO mice are capable of becoming allergic. We
hypothesize that epithelial cells are the necessary source of IL-33 that drives allergic
sensitization while mast cell-derived IL-33 is the critical signal for inflammation after
sensitization has occurred. We will examine this hypothesis using murine models of food allergy and
anaphylaxis that we have developed. Since food allergy is increasing in prevalence and there are
very few therapeutic options available at this time, our work has the potential to facilitate new
therapies for these patients. We propose to test our hypothesis with two distinct specific aims
that address the overall theme of 1) sensitization and 2) elicitation of allergic responses. These
aims are:
Specific Aim 1: Determine the role of cell-specific IL-33 expression in the generation of
peanut-specific antibody and T cell responses.
Specific Aim 2: Determine the mechanisms through which IL-33 regulates the generation of tissue
inflammation to allergens.
Status | Finished |
---|---|
Effective start/end date | 2/11/14 → 1/31/20 |
Funding
- National Institute of Allergy and Infectious Diseases (5R01AI105839-05)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.